Moderna's Updated COVID Vaccine Proven Effective Against Eris Variant
TL;DR Summary
Moderna's new Covid vaccine has shown a strong immune response against the Eris variant and another rapidly spreading strain in an early clinical trial. The vaccine, designed to target the omicron subvariant XBB.1.5, may also be effective against newer variants like Eris and Fornax. Pfizer's updated Covid shot has also demonstrated effectiveness against XBB.1.5 and Eris in a recent trial on mice. The vaccines from Moderna, Pfizer, and Novavax are expected to be rolled out pending FDA approvals.
- Moderna says new Covid vaccine was effective against Eris variant in early trial CNBC
- Moderna’s updated COVID-19 shot shows ‘significant boost’ in antibodies against ‘Eris’ strain The Hill
- Maine experiencing an uptick in COVID-19, but new vaccine booster is on the way Press Herald
- Moderna's updated COVID vaccine effective against 'Eris' variant in humans Reuters
- Former FDA Commissioner Dr. Scott Gottlieb says nothing suggests new 'Eris' Covid variant is more pathogenic t Daily Mail
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
1 min
vs 2 min read
Condensed
67%
237 → 78 words
Want the full story? Read the original article
Read on CNBC